Patrys Limited (ASX:PAB)
Australia · Delayed Price · Currency is AUD 0.0340
0.00 (0.00%)
Sep 17, 2026, 3:30 PM AEST
Patrys Market Cap
Patrys has a market cap or net worth of 22.94 million as of September 17, 2026. Its market cap has increased by 150.29% in one year.
Market Cap
22.94M
Enterprise Value
19.58M
Revenue
8.99K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
ChartMarket Cap Chart
Since July 13, 2007, Patrys's market cap has decreased from 97.06M to 22.94M, a decrease of -76.36%. That is a compound annual growth rate of -7.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 22.94M | 140.50% |
| Dec 31, 2025 | 9.54M | 15.93% |
| Dec 31, 2024 | 8.23M | -50.00% |
| Dec 29, 2023 | 16.46M | -70.36% |
| Dec 30, 2022 | 55.54M | -27.00% |
| Dec 31, 2021 | 76.08M | 75.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nexsen | 33.03M |
| Radiopharm Theranostics | 30.36M |
| NeuroScientific Biopharmaceuticals | 25.33M |
| Proteomics International Laboratories | 23.15M |
| Imugene | 23.02M |
| Noxopharm | 20.58M |
| EZZ Life Science Holdings | 19.53M |
| Argenica Therapeutics | 19.27M |